Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
72
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell

Ming-Jun Zheng1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Jing Wang1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Hui-Min Wang1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Ling-Ling Gao1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Xiao Li1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Wen-Chao Zhang1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Rui Gou1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Qian Guo1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Xin Nie1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
,
Juan-Juan Liu1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]
&
Bei Lin1 Department of Gynaecology and Obstetrics, Shengjing Hospital Affiliated to China Medical University, Heping District, Shenyang 110004, Liaoning, China, [email protected];2 Key Laboratory of Maternal-Fetal Medicine of Liaoning Province, Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Liaoning, China, [email protected]Correspondence[email protected]
 show all
Pages 7745-7761 | Published online: 02 Nov 2018

References

  • CortezAJTudrejPKujawaKALisowskaKMAdvances in ovarian cancer therapyCancer Chemother Pharmacol2018811173829249039
  • ColomboPEFabbroMTheilletCBibeauFRouanetPRay-CoquardISensitivity and resistance to treatment in the primary management of epithelial ovarian cancerCrit Rev Oncol Hematol201489220721624071502
  • RheeSGChaeHZKimKPeroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signalingFree Radic Biol Med200538121543155215917183
  • RheeSGKangSWChangTSJeongWKimKPeroxiredoxin, a novel family of peroxidasesIUBMB Life2001521–2354111795591
  • NeumannCACaoJManevichYPeroxiredoxin 1 and its role in cell signalingCell Cycle20098244072407819923889
  • DingCFanXWuGPeroxiredoxin 1 – an antioxidant enzyme in cancerJ Cell Mol Med201721119320227653015
  • RenPYeHDaiLPeroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinomaOncol Rep20133052297230324009050
  • ChenMFKengPCShauHInhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expressionInt J Radiat Oncol Biol Phys200664258159116414373
  • WangXHeSSunJMDelcuveGPDavieJRSelective association of peroxiredoxin 1 with genomic DNA and COX-2 upstream promoter elements in estrogen receptor negative breast cancer cellsMol Biol Cell201021172987299520631257
  • ChungKHLeeDHKimYProteomic identification of over-expressed PRDX 1 and its clinical implications in ovarian carcinomaJ Proteome Res20109145145719902980
  • JalaliBMBogackiMDietrichMLikszoPWasielakMProteomic analysis of porcine endometrial tissue during peri-implantation period reveals altered protein abundanceJ Proteomics2015125768825976747
  • ZouSShenQHuaYJiangWZhangWZhuXProteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancerReprod Sci201320111356136423599374
  • SubramanianATamayoPMoothaVKGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesProc Natl Acad Sci U S A200510243155451555016199517
  • BaderGDHogueCWAn automated method for finding molecular complexes in large protein interaction networksBMC Bioinformatics20034212525261
  • HoskinsERHoodBLSunMKrivakTCEdwardsRPConradsTPProteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulationPLoS One201169e2505621980378
  • DuanJLangYSongCXiongJWangYYanYsiRNA targeting of PRDX3 enhances cisplatin-induced apoptosis in ovarian cancer cells through the suppression of the NF-κB signaling pathwayMol Med Rep2013751688169423503975
  • PakJHChoiWHLeeHMPeroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cellsCancer Invest2011291212821166495
  • HeTBanach-LatapyAVernisLDardalhonMChanetRHuangMEPeroxiredoxin 1 knockdown potentiates β-lapachone cytotoxicity through modulation of reactive oxygen species and mitogen-activated protein kinase signalsCarcinogenesis201334476076923239746
  • WendPHollandJDZieboldUBirchmeierWWnt signaling in stem and cancer stem cellsSemin Cell Dev Biol201021885586320837152
  • TalbotLJBhattacharyaSDKuoPCEpithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignanciesInt J Biochem Mol Biol20123211713622773954
  • HaBKimEKKimJHHuman peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activityBiochem Biophys Res Commun20124211333722475482
  • YerlikayaAYontemMSignificance of Ubiquitin Proteasome Pathway in CancerRecent Pat Anticancer Drug Discov20138329830923061719
  • GuoQJMillsJNBandurragaSGMicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancerBreast Cancer Res2013154R7023971998
  • LeeWChoiKSRiddellJHuman peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2J Biol Chem200728230220112202217519234
  • Turner-IveyBManevichYSchulteJRole for Prdx1 as a specific sensor in redox-regulated senescence in breast cancerOncogene201332455302531423334324
  • TaniuchiKFurihataMHanazakiKPeroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activityPancreas201544233134025426613

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.